Lucky Pfizer CEO Bourla Cashes Out $5.6M Worth of Stock—Perfectly Legally—as COVID Vaccine Data Lifts Market
On Monday before the stock market opened, Pfizer announced that its COVID-19 mRNA vaccine had proven 90% effective so far in its ongoing late-stage trial, lifting the company’s shares nearly 8% through the course of the day...
Login to comment.